IMR Press / RCM / Volume 23 / Issue 8 / DOI: 10.31083/j.rcm2308260
Open Access Systematic Review
Assessment of Endothelial Dysfunction in Patients with Kawasaki Disease: A Meta-Analysis
Show Less
1 Department of Ultrasound, Shengjing Hospital of China Medical University, 110004 Shenyang, Liaoning, China
*Correspondence: (Guang Song)
Academic Editors: Carmela Rita Balistreri and Teruo Inoue
Rev. Cardiovasc. Med. 2022, 23(8), 260;
Submitted: 18 April 2022 | Revised: 31 May 2022 | Accepted: 15 June 2022 | Published: 20 July 2022
(This article belongs to the Section Heart Diseases)
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.

Background: Kawasaki disease (KD) is a well-known systemic inflammatory vasculitis. Endothelial dysfunction is one of most easily overlooked non-coronary complications of KD. Several studies have assessed endothelial dysfunction using flow-mediated dilatation (FMD), nitroglycerin-mediated dilation (NMD), and biomarkers (E-selectin, P-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cellular adhesion molecule-1 (VCAM-1)). However, the results were inconsistent and incomplete. Methods: We searched five databases for eligible studies until March 8, 2022. The summarized weighted mean difference (WMD) with 95% confidence intervals (CIs) were estimated for FMD, NMD, and four biomarkers level between KD and healthy children. A meta-analysis with subgroup analysis was conducted. Results: 40 studies with a total of 2670 children (1665 KD patients and 1005 healthy children) were identified. During the acute phase, KD patients had lower FMD compared to the control group (WMD = –10.39, 95% CI: –13.80– –6.98). During the subacute phase, KD patients had lower FMD compared to the control group (WMD = –15.07, 95% CI: –17.61– –12.52). During the convalescence phase, KD patients had lower FMD and similar NMD compared to the control group (WMD = –4.95, 95% CI: –6.32– –3.58; WMD = –0.92, 95% CI: –2.39–0.55, respectively). During the convalescence phase, those KD patients without coronary artery lesion (CAL), with CAL, even with coronary artery aneurysm, had progressively lower FMD compared to healthy children (WMD = –3.82, 95% CI: –7.30– –0.34; WMD = –6.32, 95% CI: –7.60– –5.04; and WMD = –6.97, 95% CI: –7.99– –5.95, respectively). Compared to KD patients without CAL, those with CAL had lower FMD (WMD = –1.65, 95% CI: –2.92– –0.37). KD patients had higher levels of E-selectin, P-selectin, and ICAM-1 compared to healthy controls during different phases. KD patients had a higher level of VCAM-1 compared to healthy controls only during the acute phase (WMD = 61.62, 95% CI: 21.38–101.86). Conclusions: Endothelial dysfunction is present since the onset of KD and persists for years, confirmed by the measurement of FMD and biomarkers from different phases. An assumption is advanced that FMD impairment (the severity of endothelial dysfunction) may be positively correlated with CAL severity during the convalescence phase.

mucocutaneous lymph node syndrome
endothelial function
flow-mediated dilatation
Fig. 1.
Back to top